Comparison of central precocious puberty frequency before and during COVID-19: a systematic review and meta-analysis

Jianwei Zhang1, Jinliang Xu1, Xiaoli Tang1

  • 1Shaoxing Maternity and Child Health Care Hospital, Shaoxing, 312000, China.

BMC Endocrine Disorders
|October 17, 2024
PubMed

Insights

Central precocious puberty (CPP) significantly increased during the COVID-19 pandemic. Further research is needed to understand the factors contributing to this rise in early puberty.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Epidemiology

Background:

  • Central precocious puberty (CPP) is a condition where puberty begins unusually early.
  • The COVID-19 pandemic has been associated with various health changes in children, necessitating investigation into its impact on endocrine disorders.

Purpose of the Study:

  • To assess the prevalence of central precocious puberty (CPP) during the COVID-19 pandemic.
  • To compare CPP incidence before and during the pandemic using a systematic review and meta-analysis.

Main Methods:

  • A systematic review and meta-analysis were conducted following PRISMA guidelines.
  • Searched PubMed, Embase, Web of Science, and WANFANG databases (Jan 2019 - Mar 2023).
  • Included studies on children ≤15 years with defined CPP criteria, comparing pre-pandemic and pandemic periods.

Main Results:

  • The meta-analysis included 17 studies.
  • CPP occurrence was significantly elevated during the COVID-19 pandemic (OR = 2.57; 95% CI, 1.85-3.56).
  • A slight, non-significant increase in BMI SDS was observed in CPP patients during the pandemic.

Conclusions:

  • CPP frequency significantly increased during the COVID-19 pandemic.
  • The findings highlight a potential link between the pandemic and early puberty onset.
  • Further large-scale cohort studies are recommended to identify specific pathogenic factors.
Abstract